Search

everythinglearnresearchcommunity

for

Search:↓

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

LGD1069 effectively prevents breast tumors in mice without toxicity.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Finasteride may help treat Pseudomonas aeruginosa infections by reducing its harmful activities.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

New steroids were effective in blocking male hormone receptors in hamster prostates.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

PM-9, like finasteride, may help treat certain diseases by blocking a key enzyme.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Finasteride effectively treats benign prostatic hyperplasia by reducing prostate size and improving urinary symptoms.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.